The transwell assays revealed an increase in the migratory and invasive capabilities of GBM cells following the upregulation of XTP6, whereas the reduction of NDH2 expression partially attenuated these phenomena (Fig. 3S and S3O). This evidence concerns the gene DHX9 and glioblastoma.